Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.67 Insider Own28.39% Shs Outstand24.49M Perf Week-8.13%
Market Cap114.18M Forward P/E- EPS next Y-1.15 Insider Trans-1.44% Shs Float17.66M Perf Month-8.86%
Income-40.30M PEG- EPS next Q-0.46 Inst Own47.07% Short Float5.41% Perf Quarter-10.10%
Sales63.15M P/S1.81 EPS this Y25.34% Inst Trans17.14% Short Ratio4.29 Perf Half Y-33.38%
Book/sh0.58 P/B7.94 EPS next Y24.34% ROA-61.70% Short Interest0.96M Perf Year-54.52%
Cash/sh1.51 P/C3.07 EPS next 5Y- ROE-459.89% 52W Range4.03 - 10.84 Perf YTD-30.06%
Dividend Est.- P/FCF- EPS past 5Y5.17% ROI-73.20% 52W High-57.29% Beta1.02
Dividend TTM- Quick Ratio3.23 Sales past 5Y49.61% Gross Margin68.97% 52W Low14.89% ATR (14)0.32
Dividend Ex-Date- Current Ratio4.13 EPS Y/Y TTM37.33% Oper. Margin-71.62% RSI (14)44.33 Volatility5.68% 7.01%
Employees227 Debt/Eq2.87 Sales Y/Y TTM40.03% Profit Margin-63.82% Recom1.00 Target Price14.20
Option/ShortYes / Yes LT Debt/Eq2.83 EPS Q/Q63.26% Payout- Rel Volume0.45 Prev Close4.55
Sales Surprise1.74% EPS Surprise52.95% Sales Q/Q39.42% EarningsMay 09 AMC Avg Volume223.04K Price4.63
SMA20-2.91% SMA50-12.79% SMA200-20.02% Trades Volume100,112 Change1.76%
Date Action Analyst Rating Change Price Target Change
May-31-22Initiated Lake Street Buy $17
Dec-03-19Initiated Piper Jaffray Overweight
Dec-03-19Initiated JMP Securities Mkt Outperform
Dec-03-19Initiated Jefferies Buy
Dec-03-19Initiated Canaccord Genuity Buy
Jun-04-24 04:05PM
May-20-24 04:03PM
May-13-24 11:01AM
May-10-24 04:05PM
10:15AM Loading…
May-09-24 04:05PM
May-02-24 04:10PM
Apr-25-24 07:00AM
Apr-15-24 07:00AM
Apr-08-24 07:00AM
Mar-22-24 09:46AM
Mar-21-24 08:53PM
05:30PM Loading…
Mar-20-24 07:00AM
Feb-29-24 07:00AM
Feb-23-24 04:05PM
Jan-19-24 04:05PM
Dec-15-23 04:05PM
Dec-05-23 07:00AM
Nov-16-23 07:00AM
Nov-12-23 12:20PM
Nov-10-23 04:05PM
Nov-09-23 04:05PM
Oct-26-23 07:00AM
04:05PM Loading…
Sep-18-23 04:05PM
Aug-16-23 07:00AM
Aug-11-23 10:03AM
Aug-10-23 09:18AM
Aug-09-23 06:05PM
Aug-04-23 04:02PM
Jul-26-23 07:00AM
Jul-06-23 10:09AM
Jun-18-23 07:51PM
Jun-15-23 07:00AM
May-25-23 07:00AM
May-21-23 10:30AM
May-19-23 07:00AM
May-12-23 07:44AM
May-11-23 05:25PM
May-09-23 07:00AM
May-08-23 04:30PM
May-02-23 07:00AM
Apr-30-23 08:26AM
Apr-28-23 06:47PM
Apr-27-23 07:00AM
Apr-18-23 11:00PM
Apr-03-23 06:14AM
Mar-29-23 07:00AM
Mar-24-23 07:15AM
Mar-23-23 07:00AM
Mar-22-23 06:01AM
Mar-21-23 05:15PM
Mar-16-23 07:00AM
Feb-28-23 07:00AM
Feb-24-23 04:02PM
Feb-21-23 07:00AM
Feb-14-23 07:00AM
Jan-20-23 04:05PM
Jan-09-23 07:00AM
Dec-23-22 05:46AM
Dec-21-22 07:00AM
Dec-09-22 04:02PM
Nov-21-22 07:00AM
Nov-12-22 07:42AM
Nov-09-22 05:25PM
Nov-03-22 07:00AM
Oct-28-22 04:05PM
Oct-27-22 07:00AM
Oct-26-22 07:00AM
Oct-24-22 10:24AM
Sep-01-22 07:00AM
Aug-23-22 04:01PM
Aug-19-22 10:52AM
Aug-18-22 04:01PM
Aug-16-22 12:01PM
Aug-15-22 10:20PM
Aug-10-22 10:30PM
Aug-05-22 07:00AM
Aug-04-22 07:00AM
Jul-29-22 04:01PM
Jul-27-22 07:00AM
Jul-20-22 07:00AM
Jul-08-22 06:45AM
Jun-24-22 08:52AM
Jun-23-22 11:02AM
TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORBIMED ADVISORS LLC10% OwnerJul 02 '24Sale4.5436,600166,1642,407,242Jul 02 04:54 PM
ORBIMED ADVISORS LLC10% OwnerJul 01 '24Sale4.6813,70064,1162,443,842Jul 02 04:54 PM
ORBIMED ADVISORS LLC10% OwnerJun 28 '24Sale4.74378,0001,791,7202,457,542Jul 02 04:54 PM
Firestone Gregory A.Chief Business OfficerDec 05 '23Buy5.652,60014,68835,511Dec 07 04:02 PM
KOBLISH ANTONYChief Executive OfficerNov 14 '23Buy4.5411,00049,976303,634Nov 14 08:01 PM
Cuca RobertoCOO and CFONov 14 '23Buy4.4910,00044,93862,371Nov 14 08:02 PM